Boss, Macquarie Group · angel in 1 deal
| Role | Organisation | Sources |
|---|---|---|
| Boss | Macquarie Group | Startup Daily (17 Oct 2023), Startup Daily (8 Dec 2021) |
| Executive (former) | Macquarie Bank | Startup Daily, ferronova.com.au |
Every published round Allan Moss took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Skykraft | Unnamed stage | Nov 2021 | $3.5m | Participant | Techboard, Startup Daily (13 Dec 2021), @AuManufacturing, Startup Daily (8 Dec 2021) |
Companies Allan Moss has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Skykraft | Nov 2021 | 1 | 0 |
Fund closes reported for Allan Moss, as distinct from the investments it has made.
Companies Allan Moss has backed that another company then bought. An exit for the holding, not a deal Allan Moss did.
Stories naming Allan Moss. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Canberra startup Skykraft raised $120 million for its space-based air traffic management system, led by Foresight's Australian arm with Main Sequence Ventures and OPTrust, following an earlier $3.5 million round.
Adelaide cancer-focused biotech Ferronova has secured fresh backing: an investor round led by Irish strategic partner Renew Pharmaceuticals plus a federal research grant, to speed clinical trials in stomach and brain cancers.
Also SmartCompany·SmartCompany·Startup Daily·Business News Australia·Startup Daily
Adelaide biotech Ferronova announced an A$11 million package: an A$8 million round led by Ireland's Renew Pharmaceuticals plus an A$3 million government CRC-P grant, with existing shareholders Uniseed and Artesian also participating.